Pilulka Lekarny AS (XPRA:PINK) Shares Outstanding (EOP): 3 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XPRA:PINK Pilulka Lekarny AS XPRA:PINK
47 GF Score
Price Kč112.00
GF Value Kč113.37
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Pilulka Lekarny AS Shares Outstanding (EOP)?

Pilulka Lekarny AS XPRA:PINK -0.88% 47 Shares Outstanding (EOP) is 3 Mil as of Dec. 2025. GuruFocus rates XPRA:PINK with a GF Score™ of 47/100 and a GF Value™ of Kč113.37 (Fairly Valued). The stock has 6 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Pilulka Lekarny AS's shares outstanding for the quarter that ended in Dec. 2025 was 3 Mil.

Pilulka Lekarny AS's quarterly shares outstanding stayed the same from Dec. 2024 (3 Mil) to Dec. 2025 (3 Mil).

Pilulka Lekarny AS's annual shares outstanding stayed the same from Dec. 2024 (3 Mil) to Dec. 2025 (3 Mil).


Pilulka Lekarny AS  (XPRA:PINK) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Pilulka Lekarny AS Shares Outstanding (EOP) Related Terms


Pilulka Lekarny AS Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Pilulka Lekarny AS's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pilulka Lekarny AS Shares Outstanding (EOP) Chart

Pilulka Lekarny AS Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 2.53 2.55 2.71 2.71 2.71

Pilulka Lekarny AS Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Jun24 Dec24 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial 2.55 2.71 2.71 2.71 2.71

Pilulka Lekarny AS Shares Outstanding (EOP) Competitor Comparison

For the Pharmaceutical Retailers subindustry, Pilulka Lekarny AS's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pilulka Lekarny AS Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pilulka Lekarny AS's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Pilulka Lekarny AS's Shares Outstanding (EOP) falls into.


XPRA:PINK
47GF Score
Pilulka Lekarny AS XPRA:PINK
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pilulka Lekarny AS Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 3 Mil mean?
Pilulka Lekarny AS (XPRA:PINK) has a Shares Outstanding (EOP) of 3 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on Pilulka Lekarny AS and its competitors.
Is Pilulka Lekarny AS's Shares Outstanding (EOP) too high?
Pilulka Lekarny AS's current Shares Outstanding (EOP) is 3 Mil. Overall, Pilulka Lekarny AS has a GF Score™ of 47/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Pilulka Lekarny AS's Shares Outstanding (EOP) compare to competitors?
Pilulka Lekarny AS's Shares Outstanding (EOP) of 3 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Pilulka Lekarny AS and its competitors. Pilulka Lekarny AS's current Shares Outstanding (EOP) is 3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pilulka Lekarny AS stock overvalued right now?
Based on GuruFocus' analysis, Pilulka Lekarny AS (XPRA:PINK) is currently considered Fairly Valued. The stock's GF Value™ is Kč113.37, compared to a current price of Kč112.00 — trading 1.2% below its estimated fair value. The current Shares Outstanding (EOP) is 3 Mil. Pilulka Lekarny AS's overall GF Score™ is 47/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Pilulka Lekarny AS (XPRA:PINK), the current Shares Outstanding (EOP) is 3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pilulka Lekarny AS (XPRA:PINK) Overvalued in 2026?

Based on GuruFocus' analysis, Pilulka Lekarny AS stock appears to be undervalued. The current stock price of Kč112.00 is trading 1.2% below its estimated GF Value™ of Kč113.37. GuruFocus considers Pilulka Lekarny AS to be Fairly Valued.

Key valuation signals for XPRA:PINK:

  • Shares Outstanding (EOP): 3 Mil
  • GF Value™: Kč113.37 vs. price of Kč112.00 (1.2% below fair value)
  • GF Score™: 47/100 with 6 warning signs

No single metric tells the full story. See the XPRA:PINK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Pilulka Lekarny AS Business Description

Address Drahobejlova 1073/36, Prague, CZE, 190 00
Pilulka Lekarny AS operates an online pharmaceutical store by distribution of medicinal products. The store offers over-the-counter-drugs, dietary supplements, baby foods, mother care products, cosmetics, other prescription drugs, sport nutritional products, diagnostic test kits, orthopaedic supplies, first aid kits, and other related products.
47GF Score

Get the complete analysis for XPRA:PINK

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Kč112.00
Price
Kč113.37
GF Value